Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
Empirical Formula (Hill Notation):
C21H15N5O3S2
CAS Number:
Molecular Weight:
449.51
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352202
MDL number:
assay
~98% (HPLC)
Quality Level
form
solid
solubility
DMSO: soluble
storage temp.
room temp
SMILES string
O=C1Nc2ccc3ncsc3c2\C1=C\Nc4ccc(cc4)S(=O)(=O)Nc5ccccn5
InChI
1S/C21H15N5O3S2/c27-21-15(19-16(25-21)8-9-17-20(19)30-12-24-17)11-23-13-4-6-14(7-5-13)31(28,29)26-18-3-1-2-10-22-18/h1-12,23H,(H,22,26)(H,25,27)/b15-11-
InChI key
GCYXEGSPUDSZJY-PTNGSMBKSA-N
Gene Information
human ... CDC2(983), CDK2(1017)
Biochem/physiol Actions
Initially characterized as an inhibitor of cyclin-dependent kinase 2 (CDK2), subsequent research has shown GW8510 to be non-selective.
Legal Information
Sold for research purposes under agreement from GlaxoSmithKline
Storage Class
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type N95 (US)
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Related Content
Datasheet
Yuan Wang et al.
Cell chemical biology, 23(7), 862-874 (2016-07-19)
The use of potent and selective chemical tools with well-defined targets can help elucidate biological processes driving phenotypes in phenotypic screens. However, identification of selective compounds en masse to create targeted screening sets is non-trivial. A systematic approach is needed to
Ping Chen et al.
Clinical science (London, England : 1979), 132(13), 1417-1433 (2018-06-02)
Although chemotherapeutic regimen containing gemcitabine is the first-line therapy for advanced lung squamous cell carcinoma (LSCC), gemcitabine resistance remains an important clinical problem. Some studies suggest that overexpressions of ribonucleotide reductase (RNR) subunit M2 (RRM2) may be involved in gemcitabine
Kayode K Ojo et al.
Antimicrobial agents and chemotherapy, 52(10), 3710-3717 (2008-07-23)
Development of a safe, effective, and inexpensive therapy for African trypanosomiasis is an urgent priority. In this study, we evaluated the validity of Trypanosoma brucei glycogen synthase kinase 3 (GSK-3) as a potential drug target. Interference with the RNA of